论文信息 - Routine molecular point-of-care testing for SARS-CoV-2 reduces hospital-acquired COVID-19 - 字舞流文

Routine molecular point-of-care testing for SARS-CoV-2 reduces hospital-acquired COVID-19

F. Borca | T. Clark | H. Lin | M. Stammers | N. Brendish | S. Poole | A. Tanner | Robert Livingstone | T. Smith

[1] C. Workman,et al. Superspreaders drive the largest outbreaks of hospital onset COVID-19 infections , 2021, eLife.

[2] J. Read,et al. Hospital-acquired SARS-CoV-2 infection in the UK's first COVID-19 pandemic wave , 2021, The Lancet.

[3] Graham W. Taylor,et al. Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England , 2021, Nature.

[4] D. Oliver. David Oliver: Could we do better on hospital acquired covid-19 in a future wave? , 2021, BMJ.

[5] S. Ewings,et al. Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective, interventional, non-randomised, controlled study , 2020, The Lancet Respiratory Medicine.

[6] David A. Schoenfeld,et al. Partial residuals for the proportional hazards regression model , 1982 .

[7] L. Nicolle,et al. Prevention of hospital acquired infections: a practical guide. , 2002 .